On 14 June last year, the European Haemophilia Consortium (EHC) held a Round Table of Stakeholders on ‘Hepatitis C.’ Two very important and timely topics were […]
One of the most common topics for discussion between SIBF members is the complex and worrying issue of benefits. This is certainly the case during the […]
Much of our recent research has focussed around the side-effects of past and current medications that have been offered to treat Hepatitis C of people with […]
The Penrose Inquiry generated a large quantity of data. Here we extract and illustrate the estimated numbers of people infected with Hepatitis C from 1970 to […]
Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Our Cookie Policy OkNoCookie policy